September 16, 2025Asian Pacific Journal of Cancer PreventionOpen Access

Survival and Prognostic Determinants after IMRT and 3D Radiotherapy in Metachronus Bone – Only Spinal Metastasis of Breast Cancer: A Prospective Phase II Trial

View Full Paper

Ask AI

Bookmark

Authors

AYA. Youssif AAAsmaa Abdella SESummar El-Morshidy

Discussion

Member takes

Implication

Prospective Phase II trial identifies prognostic factors affecting survival in breast cancer patients, suggesting targeted radiotherapy improves outcomes.

Key Points

The five-year survival rate for patients was 79%, indicating effective radiotherapy for oligometastatic breast cancer.
Key factors influencing overall survival include age over 50, multiple metastases, and treatment history.
The observational analysis confirms that triple-positive histology and higher radiation doses are associated with longer survival.
Prolonged radiotherapy schedules may enhance survival in patients with specific metastatic breast cancer characteristics.

Cite This Study

Youssif et al. (2025) studied this question.

synapsesocial.com/papers/68d42056713b0b5dfea692cb https://doi.org/10.31557/apjcp.2025.26.9.3423

View Full Paper

Ask AI

Bookmark

Implication

Prospective Phase II trial identifies prognostic factors affecting survival in breast cancer patients, suggesting targeted radiotherapy improves outcomes.

Survival and Prognostic Determinants after IMRT and 3D Radiotherapy in Metachronus Bone – Only Spinal Metastasis of Breast Cancer: A Prospective Phase II Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Survival and Prognostic Determinants after IMRT and 3D Radiotherapy in Metachronus Bone – Only Spinal Metastasis of Breast Cancer: A Prospective Phase II Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider